Finance
Derivatives
Advising on the laws of the BVI, the Cayman Islands, Ireland, Jersey and Luxembourg, our global Derivatives team provides expert legal advice to swap dealers, prime brokers and other financial institutions on issues of netting and collateral in relation to ISDA and repo / securities lending agreements. We also advise on issues such as capacity, authorisation and enforceability against specific counterparties.
Derivatives
Our global Derivatives team advises swap dealers, prime brokers and other financial institutions on issues of netting and collateral in relation to the International Swaps and Derivatives Association (ISDA) and repo / securities lending agreements.
The team also advises on issues such as capacity, authorisation and enforceability against specific counterparties.
Our Irish practice has developed particular expertise advising Irish-established funds (including Common Contractual Funds and UCITS) on netting and segregation issues.
We currently provide Cayman Islands legal opinions to the following:
- ISDA
- Securities Industry and Financial Markets Association (fka the Bond Market Association)
- International Capital Market Association
- Bundesverband Deutscher Banken (Federal Association of German Banks)
- Futures and Options Association
- Foreign Exchange Committee
- British Bankers' Association
Related Contacts
KNOWLEDGE
- ICLG Derivatives 2022 Cayman Islands 23 June 2022
- The Regulatory 15/15: June 2022 14 June 2022
- Growth in Master Islamic Investment Platforms Facilitated by the Offshore Centres 10 June 2022
- Legal Business Offshore Report Keeping a Weather Eye 02 June 2022
- Securitisation Guide 2022 Cayman Islands 27 May 2022
NEWS & DEALS
- Maples Group Wins Three Awards at China Business Law Awards 2022 15 June 2022
- Maples Group Wins Nine Finance Dublin Deals of the Year Awards 2022 01 June 2022
- Maples Group Welcomes 13 New Associates to its Irish Law Firm 20 May 2022
- Maples Group Announces Partner and Of Counsel Promotions in the Caribbean Region 12 May 2022
- Maples Advises on First Royalty-Backed Financing in China's Biopharmaceutical Industry 04 May 2022